US Stock MarketDetailed Quotes

RAPHAEL PHARMACEUTICAL INC (RAPH)

Watchlist
  • 1.400
  • 0.0000.00%
15min DelayClose Jul 28 11:53 ET
28.25MMarket Cap-20.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RAPHAEL PHARMACEUTICAL INC (RAPH) Cash Flow

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
2021/Q2
2021/Q1
Operating Cash Flow
+174.19%46.00K
+78.75%-17.00K
+86.24%-30.00K
-21.51%-209.00K
+29.55%-62.00K
+84.03%-80.00K
-1.40%-218.00K
+56.89%-172.00K
+68.23%-88.00K
-229.61%-501.00K
+13.31%-215.00K
-386.59%-399.00K
+60.60%-277.00K
+45.91%-152.00K
+18.69%-248.00K
+36.43%-82.00K
---703.00K
---281.00K
---305.00K
---129.00K
Net cash flow from continuing operations
+174.19%46.00K
+78.75%-17.00K
+86.24%-30.00K
-21.51%-209.00K
+29.55%-62.00K
+84.03%-80.00K
-1.40%-218.00K
+56.89%-172.00K
+68.23%-88.00K
-229.61%-501.00K
+13.31%-215.00K
-386.59%-399.00K
+60.60%-277.00K
+45.91%-152.00K
+18.69%-248.00K
+36.43%-82.00K
---703.00K
---281.00K
---305.00K
---129.00K
Net Income from Continuing Operations
+30.89%-273.00K
+21.78%-255.00K
-29.84%-322.00K
+22.00%-429.00K
-737.10%-395.00K
+55.03%-326.00K
+40.53%-248.00K
-108.33%-550.00K
+105.62%62.00K
+49.76%-725.00K
+33.49%-417.00K
-42.70%-264.00K
-94.88%-1.10M
-246.88%-1.44M
-62.02%-627.00K
+27.45%-185.00K
---566.00K
---416.00K
---387.00K
---255.00K
Depreciation & Depletion & Amortization
----
----
----
----
----
----
----
----
----
----
--0.00
--1.00K
--0.00
--0.00
--0.00
--0.00
----
----
----
----
Change in Working Capital
+7850.00%318.00K
-19.11%199.00K
+1016.13%284.00K
-93.92%23.00K
+101.14%4.00K
-42.12%246.00K
-1650.00%-31.00K
+377.94%378.00K
-1446.15%-350.00K
+367.03%425.00K
-97.75%2.00K
-232.04%-136.00K
+118.98%26.00K
-32.59%91.00K
+8.54%89.00K
-18.25%103.00K
---137.00K
--135.00K
--82.00K
--126.00K
-Change in Payables and Accrued Expense
+116.40%31.00K
-99.20%2.00K
-123.68%-85.00K
-84.90%58.00K
+50.39%-189.00K
-40.86%249.00K
+62.75%-38.00K
+664.71%384.00K
-714.52%-381.00K
+297.17%421.00K
-10300.00%-102.00K
-1.49%-68.00K
-34.04%62.00K
-19.08%106.00K
+105.56%1.00K
-348.15%-67.00K
--94.00K
--131.00K
---18.00K
--27.00K
-Change in Other Current Assets
-233.33%-4.00K
+300.00%6.00K
+371.43%33.00K
-483.33%-35.00K
+175.00%3.00K
-175.00%-3.00K
-93.27%7.00K
+91.18%-6.00K
+76.47%-4.00K
+126.67%4.00K
+18.18%104.00K
-140.00%-68.00K
+93.03%-17.00K
-475.00%-15.00K
-12.00%88.00K
+71.72%170.00K
---244.00K
--4.00K
--100.00K
--99.00K
-Change In Other Working Capital
+171.85%291.00K
--191.00K
----
----
---405.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from investing
----
----
----
+100.00%0.00
----
----
----
---1.00K
----
----
----
--0.00
--0.00
----
----
----
--0.00
--0.00
--0.00
--0.00
Net Cash Flow from Continuing Investing Activities
----
----
----
+100.00%0.00
----
----
----
---1.00K
----
----
----
--0.00
--0.00
----
----
----
--0.00
----
----
----
Net PPE Purchase and Sale
----
----
----
+100.00%0.00
----
----
----
---1.00K
----
----
----
--0.00
--0.00
----
----
----
--0.00
----
----
----
Financing Cash Flow
-109.76%-4.00K
--0.00
-100.00%0.00
+4.35%240.00K
+115.79%41.00K
-100.00%0.00
-82.64%50.00K
+54.36%230.00K
-95.97%19.00K
+515.18%689.00K
-4.64%288.00K
+1390.00%149.00K
-42.37%472.00K
+12.00%112.00K
-41.13%302.00K
-77.27%10.00K
--819.00K
--100.00K
--513.00K
--44.00K
Net Cash Flow from Continuing Financing Activities
-109.76%-4.00K
--0.00
-100.00%0.00
+4.35%240.00K
+115.79%41.00K
-100.00%0.00
-82.64%50.00K
+54.36%230.00K
-95.97%19.00K
+515.18%689.00K
-4.64%288.00K
+1390.00%149.00K
-42.37%472.00K
+12.00%112.00K
-41.13%302.00K
-77.27%10.00K
--819.00K
--100.00K
--513.00K
--44.00K
Net Issuance Payments Of Debt
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--130.00K
--44.00K
Net Common Stock Issuance
--3.00K
--0.00
-100.00%0.00
+33.33%240.00K
-100.00%0.00
-100.00%0.00
-39.39%100.00K
+20.81%180.00K
-95.97%19.00K
+625.00%812.00K
-45.36%165.00K
+1390.00%149.00K
-42.37%472.00K
+12.00%112.00K
-18.38%302.00K
--10.00K
--819.00K
--100.00K
--370.00K
--0.00
Proceeds from Stock Option Exercised
----
----
----
-100.00%0.00
----
----
----
--50.00K
----
----
----
--0.00
----
----
----
----
----
----
----
----
Net Other Financing Charges
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
----
Ending Cash Balance
+136.84%45.00K
-92.50%3.00K
-83.33%20.00K
-82.58%50.00K
-91.74%19.00K
-86.62%40.00K
+8.11%120.00K
+655.26%287.00K
-20.14%230.00K
+221.51%299.00K
-17.78%111.00K
-53.09%38.00K
+88.24%288.00K
+151.35%93.00K
-38.07%135.00K
+710.00%81.00K
--153.00K
--37.00K
--218.00K
--10.00K
Net Change in Cash
+300.00%42.00K
+78.75%-17.00K
+82.04%-30.00K
-45.61%31.00K
+69.57%-21.00K
-142.55%-80.00K
-328.77%-167.00K
+122.80%57.00K
-135.38%-69.00K
+547.62%188.00K
+35.19%73.00K
-247.22%-250.00K
+68.10%195.00K
+76.80%-42.00K
-74.04%54.00K
+15.29%-72.00K
--116.00K
---181.00K
--208.00K
---85.00K
Beginning Cash Balance
-92.50%3.00K
-83.33%20.00K
-82.58%50.00K
-91.74%19.00K
-86.62%40.00K
+8.11%120.00K
+655.26%287.00K
-20.14%230.00K
+221.51%299.00K
-17.78%111.00K
-53.09%38.00K
+88.24%288.00K
+151.35%93.00K
-38.07%135.00K
+710.00%81.00K
+61.05%153.00K
--37.00K
--218.00K
--10.00K
--95.00K
Free Cash Flow
+174.19%46.00K
+78.75%-17.00K
+86.18%-30.00K
-20.81%-209.00K
+29.55%-62.00K
+84.03%-80.00K
-0.93%-217.00K
+56.64%-173.00K
+68.23%-88.00K
-225.32%-501.00K
+13.31%-215.00K
-386.59%-399.00K
+60.60%-277.00K
+45.20%-154.00K
+18.69%-248.00K
+36.43%-82.00K
---703.00K
---281.00K
---305.00K
---129.00K
Deadline
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Accounting Standard
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q32021/Q22021/Q1
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +12.48%
Sample Name
Sample Code
 +8.90%
Sample Name
Sample Code
 +6.04%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+3.69%
5
United Sts Brent Oil Fd Lp Unit
BNO
+2.32%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.50%
Sample Name
Sample Code
 +17.38%
Sample Name
Sample Code
 +7.12%
4
Li Auto
LI
+6.44%
5
New Oriental
EDU
+6.20%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -